Please rotate your phone to landscape, to view the virtual event.

Prof. Julien Pottecher, MD, PhD

Professor Julien Pottecher is the Head of the Surgical Intensive Care Unit, (admitting brain-injured, severe trauma and high-risk post-operative patients) at the University Hospital of Strasbourg and Professor of Anaesthesiology, Critical Care & Perioperative Medicine at the University of Strasbourg.

Prof. Pottecher actively participates in continual medical education and postgraduate teaching at the European Health Simulation Unit (UNISIMES). His main research activities focus on the pathophysiology of remote organ injuries after tissue trauma and the potential implication of Damage-Associated Molecular Patterns (DAMPs) and Neutrophil Extracellular Traps (NETs) in Trauma and pneumonia (including COVID). His research takes a translational approach facilitating the transition of research activities from bench to clinical practice within the Strasbourg Federation of Translational Research (FMTS). Clinically he is involved with the national severe trauma registry ‘TraumaBase’ (www.traumabase.eu) and is the principal investigator in both academic and industry – driven Clinical Trials.

Prof. Pottecher is currently guest of the Scientific Committee and president of the Committee for acute care surgery, vital emergencies and severe trauma (ACUTE Committee) for the French Society of Anaesthesia, Critical Care & Perioperative Medicine (SFAR). He is also a member of key European Medical Societies (ESA, ESICM, ERS, SFAR). Prof. Pottecher completed his medical training in Paris, France and later received his PhD from the University of Strasbourg in 2012. He completed his Post Doctorate in 2014 as part of the EA 3071 team which focused on ‘Mitochondria, oxidative stress and muscle protection’. In addition, he has completed diplomas in pedagogy in health sciences, ultrasound-guided haemodynamic exploration in Anaesthesia and resuscitation and statistics applied to Medicine. Prof. Pottecher is also on the editorial board of Frontiers in Immunology and reviews numerous papers. He has published over 100 peer-reviewed articles in both national and international scientific journals and has published 5 books and wrote chapters in various others. He has presented at more than 50 conferences internationally. He has received 5 awards and more than 4 research grants.

References

  1. Dunne RB and Shortt S. Comparison of bronchodilator administration with vibrating-mesh nebulizer and standard jet nebulizer in the emergency department. The American Journal of Emergency Medicine. 2018;36(4):641-646.
  2. Aerogen Internal data on file, Aug 2020
  3. Aerogen Solo System Instruction Manual. Aerogen Ltd.
  4. Ari, A. (2020). Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. In Respiratory Medicine (Vol. 167). W.B. Saunders Ltd. https://doi.org/10.1016/j.rmed.2020.105987
  5. Dugernier J, Reychler G, Wittebole X, Roeseler J, Depoortere V, Sottiaux T, et al. Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care [Internet]. 2016/07/23. 2016 Dec [cited 2018 Oct 5];6(1):73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27447788
  6. MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman RE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med [Internet]. 1985/02/01. 1985 Feb [cited 2019 Apr 17];13(2):81–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/39675081
  7. Chweich H et al. Effect on Airflow of Bronchodilator Therapy Delivered via Vibrating-Mesh versus Jet Nebulisers in Acute Asthmatics in an Emergency Department. Poster at ATS. 2019.
  8. Dugernier J et al. SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-Mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study. Pharmaceutical Research. 2017;34:290-300.